Valuation: MedPacto, Inc.

Market Cap 12TCr 8.2Cr 7.19Cr 6.7Cr 6.16Cr 12Cr 783.19Cr 12Cr 79Cr 31Cr 388.41Cr 31Cr 30Cr 1.34TCr P/E 2024
-7.42x
P/E 2025 -17.9x
Enterprise Value 8.03TCr 5.52Cr 4.84Cr 4.51Cr 4.15Cr 7.78Cr 527.29Cr 7.91Cr 54Cr 21Cr 261.5Cr 21Cr 20Cr 903.48Cr EV / Sales 2024
-
EV / Sales 2025 4,87,33,025x
Free-Float
74%
Yield 2024 *
-
Yield 2025 -
1 day+29.85%
1 week+33.08%
Current month+10.65%
1 month+23.84%
3 months-35.56%
6 months-47.35%
Current year-47.90%
1 week 2,555
Extreme 2555
3,480
1 month 2,545
Extreme 2545
3,480
Current year 2,545
Extreme 2545
7,980
1 year 2,545
Extreme 2545
8,650
3 years 2,545
Extreme 2545
17,240
5 years 2,545
Extreme 2545
69,600
10 years 2,545
Extreme 2545
1,34,200
Manager TitleAgeSince
Chief Executive Officer 72 19/06/2013
President 66 28/03/2024
Comptroller/Controller/Auditor 70 28/03/2022
Director TitleAgeSince
Director/Board Member 72 19/06/2013
Director/Board Member 66 28/03/2024
Director/Board Member 63 28/03/2024
Date Insider Type Main position Quantity % Market Cap.
04/03/25 Buy

Chairperson

15,000 0.0438%
04/03/25 Buy 10,000 0.0292%
04/03/25 Buy

Chairperson

15,000 0.0438%
Change 5-day change 1-year change 3-year change Capi.($)
+29.85%+33.08%-19.44%-74.86% 6.26Cr
-2.25%+1.55%+50.84%+70.04% 5.62TCr
-1.32%-0.97%+38.41%+77.52% 5.48TCr
+1.32%-0.13%-18.25%-14.16% 2.3TCr
+0.32%-3.36%+3.16%+391.66% 2.27TCr
-0.21%+0.84%+22.48%-7.92% 2.02TCr
0.00%+3.00%+27.41%-29.52% 1.78TCr
-0.97%+0.89%+37.28%+539.62% 1.57TCr
-6.69%-5.11%+166.00%+304.89% 1.52TCr
+0.28%+0.53%+27.09%+184.21% 1.4TCr
Average +2.03%+3.50%+33.50%+144.15% 2.4TCr
Weighted average by Cap. -1.15%+0.43%+37.74%+132.34%

Financials

2024 2025
Net sales - 3.9T 2.68 2.35 2.19 2.01 3.78 255.98 3.84 25.98 10.17 126.95 10.06 9.84 438.61
Net income -2.01TCr -1.38Cr -1.21Cr -1.13Cr -1.04Cr -1.95Cr -132.24Cr -1.98Cr -13Cr -5.25Cr -66Cr -5.2Cr -5.08Cr -226.59Cr -1.28TCr -88.05L -77.27L -71.95L -66.18L -1.24Cr -84Cr -1.26Cr -8.54Cr -3.34Cr -42Cr -3.31Cr -3.23Cr -144.13Cr
Net Debt -5.35TCr -3.68Cr -3.23Cr -3.01Cr -2.77Cr -5.18Cr -351.54Cr -5.27Cr -36Cr -14Cr -174.34Cr -14Cr -14Cr -602.34Cr -3.9TCr -2.68Cr -2.35Cr -2.19Cr -2.01Cr -3.77Cr -255.9Cr -3.84Cr -26Cr -10Cr -126.91Cr -10Cr -9.84Cr -438.48Cr
Logo MedPacto, Inc.
MedPacto, Inc. is a Korea-based company principally engaged in the research and development of biopharmaceuticals. The Company researches and develops anticancer drugs and diagnostic kits including vactosertib, MA-B2 and others. The products are used as the treatment of multiple myeloma, lung cancer, stomach cancer, colon cancer, blood cancer, triple negative breast cancer and pancreatic cancer, among others.
Employees
-
Date Price Change Volume
28/26/28 3,480.00 +29.85% 5,64,053
27/26/27 ₩2,680.00 -1.29% 1,01,560
24/26/24 ₩2,715.00 -0.18% 1,25,443
23/26/23 ₩2,720.00 +5.63% 99,651
22/26/22 ₩2,575.00 -1.90% 96,274
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A235980 Stock